Assessment of anti‑reflux treatment on pulmonary ventilation function and inflammatory cytokines in patients with stable chronic obstructive pulmonary disease combined with gastroesophageal reflux

  • Authors:
    • Hang Liu
  • View Affiliations

  • Published online on: April 18, 2018     https://doi.org/10.3892/etm.2018.6077
  • Pages: 5528-5536
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Compelling evidence has demonstrated that systemic inflammation among patients with stable chronic obstructive pulmonary disease (COPD) is linked with increased levels of inflammatory cytokines. The aim of the present study was to investigate the effects associated with anti‑reflux treatment on pulmonary ventilation function and inflammatory cytokines in patients with stable COPD and gastroesophageal reflux (GER). One hundred and thirty‑six stable COPD and GER patients were recruited for the study and randomly designated into the routine treatment and the anti GER groups. Six months prior to and after treatment, pulmonary ventilation function, 6‑min walk distance (6MWD) and times of acute exacerbation of COPD (AECOPD) were recorded. The levels of inflammatory cytokines IL‑13, IL‑18, transforming growth factor‑β1 (TGF‑βl) and tumor necrosis factor‑α (TNF‑α) in the sputum were detected by ELISA. BODE indexes, including body mass index, obstruction, dyspnea and exercise, were analyzed in order to evaluate patient prognoses. In comparison with the routine treatment group, patients in the anti‑GER group displayed improved pulmonary ventilation function, increased 6MWD as well as decreases in AECOPD, levels of IL‑13, IL‑18, TGF‑βl and TNF‑α in the sputum and BODE index 6 months after treatment. The results obtained suggested a correlation between the BODE indexes after treatment and the course of disease as well as the frequency of exacerbation. The key findings of the study suggested that conventional treatment combined with anti‑reflux treatment could effectively improve pulmonary ventilation function, while acting to decrease the levels of inflammatory cytokines and improve the prognosis of patients with stable COPD along with GER.
View Figures
View References

Related Articles

Journal Cover

June-2018
Volume 15 Issue 6

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Liu H: Assessment of anti‑reflux treatment on pulmonary ventilation function and inflammatory cytokines in patients with stable chronic obstructive pulmonary disease combined with gastroesophageal reflux. Exp Ther Med 15: 5528-5536, 2018.
APA
Liu, H. (2018). Assessment of anti‑reflux treatment on pulmonary ventilation function and inflammatory cytokines in patients with stable chronic obstructive pulmonary disease combined with gastroesophageal reflux. Experimental and Therapeutic Medicine, 15, 5528-5536. https://doi.org/10.3892/etm.2018.6077
MLA
Liu, H."Assessment of anti‑reflux treatment on pulmonary ventilation function and inflammatory cytokines in patients with stable chronic obstructive pulmonary disease combined with gastroesophageal reflux". Experimental and Therapeutic Medicine 15.6 (2018): 5528-5536.
Chicago
Liu, H."Assessment of anti‑reflux treatment on pulmonary ventilation function and inflammatory cytokines in patients with stable chronic obstructive pulmonary disease combined with gastroesophageal reflux". Experimental and Therapeutic Medicine 15, no. 6 (2018): 5528-5536. https://doi.org/10.3892/etm.2018.6077